Conference Coverage

International expert group agrees on redefining psoriasis severity

Publish date: December 1, 2020

 

FROM MEDSCAPELIVE LAS VEGAS DERMATOLOGY SEMINAR

MedscapeLive and this news organization are owned by the same parent company.

bjancin@mdedge.com

Pages

Recommended Reading

Shingrix effective in older adults with preexisting immune-mediated disorders
MDedge Family Medicine
Study highlights differences between White and Latino patients with psoriasis
MDedge Family Medicine
Data on potential risks of COVID-19 in psoriasis patients limited, but reassuring
MDedge Family Medicine
Hand eczema: Pan-JAK inhibitor delgocitinib shows dose-dependent response in phase 2b trial
MDedge Family Medicine
Biologics may protect psoriasis patients against severe COVID-19
MDedge Family Medicine
Topical tapinarof effective in pivotal psoriasis trials
MDedge Family Medicine
Methotrexate users need tuberculosis tests in high-TB areas
MDedge Family Medicine
Chronic inflammatory diseases vary widely in CHD risk 
MDedge Family Medicine
TNF inhibitor–induced psoriasis treatment algorithm maintains TNF inhibitor if possible
MDedge Family Medicine
Expanded indications likely for apremilast
MDedge Family Medicine